Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year
Filters applied: . Clear all
Page 1
Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome.
Torene R, Nirmala N, Obici L, Cattalini M, Tormey V, Caorsi R, Starck-Schwertz S, Letzkus M, Hartmann N, Abrams K, Lachmann H, Gattorno M. Torene R, et al. Among authors: starck schwertz s. Ann Rheum Dis. 2017 Jan;76(1):303-309. doi: 10.1136/annrheumdis-2016-209335. Epub 2016 Jul 29. Ann Rheum Dis. 2017. PMID: 27474763 Free PMC article. Clinical Trial.
Gene expression profiling of immunomagnetically separated cells directly from stabilized whole blood for multicenter clinical trials.
Letzkus M, Luesink E, Starck-Schwertz S, Bigaud M, Mirza F, Hartmann N, Gerstmayer B, Janssen U, Scherer A, Schumacher MM, Verles A, Vitaliti A, Nirmala N, Johnson KJ, Staedtler F. Letzkus M, et al. Among authors: starck schwertz s. Clin Transl Med. 2014 Nov 13;3:36. doi: 10.1186/s40169-014-0036-z. eCollection 2014. Clin Transl Med. 2014. PMID: 25984272 Free PMC article.